The incidence of new onset congestive heart failure and heart failure exacerbation in Veteran's Affairs patients receiving tumor necrosis factor alpha antagonists

Rheumatology International

Volumn 27, Issue 4, 2007, Pages 369-373

  Cole, Jennifer ^a,b   Busti, Anthony ^a,c   Kazi, Salahuddin ^a,d  

^a VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF SOUTH CAROLINA COLLEGE OF PHARMACY   (United States)

^c TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Congestive; Heart failure; Rheumatoid arthritis; Tumor necrosis factor

Indexed keywords

ADALIMUMAB; DAUNORUBICIN; DOXAZOSIN; DOXORUBICIN; ETANERCEPT; INFLIXIMAB; ITRACONAZOLE; PIOGLITAZONE; ROSIGLITAZONE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS;

AGED; ANTIBODIES, MONOCLONAL; ARTHRITIS, RHEUMATOID; BIOLOGICAL RESPONSE MODIFIERS; CASE-CONTROL STUDIES; FEMALE; HEART FAILURE, CONGESTIVE; HOSPITALS, VETERANS; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; RETROSPECTIVE STUDIES; TEXAS; TUMOR NECROSIS FACTOR-ALPHA; VETERANS;

EID: 33846278750     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-006-0215-3     Document Type: Article

References (23)

1. Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL (1996) Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD). J Am Coll Cardiol 27:1201-1206
2. Rauchhaus M, Doehner W, Francis DP, Davos C, Kemp M, Liebenthal C, Niebauer J, Hooper J, Volk HD, Coats AJ, Anker SD (2000) Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 102:3060-3067
3. Deswal A, Peterson NJ, Feldman AM, Young JB, White BG, Mann DL (2001) Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the vesnarinone trial (VEST). Circulation 103:2055-2059
4. Deswal A, Bozkurt B, Seta Y, Parilti-Eiswirth S, Hayes FA, Blosch C, Mann DL (1999) Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure. Circulation 99:3224-3226
5. Bozkurt B, Torre-Amione G, Warren MS, Whitmore J, Soran OZ, Feldman AM, Mann DL (2001) Results of targeted antitumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure. Circulation 103:1044-1047
6. Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT (2003) Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor alpha in patients with moderate-to-severe heart failure: results of the anti-TNF therapy against congestive heart failure (ATTACH) trial. Circulation 107:3133-3140
7. Mann DL, McMurray JV, Packer M, Swedberg K, Borer JS, Colucci WS, Drexler H, Feldman A, Kober L, Krum H, Liu P, Nieminen M, Tavazzi L, van Veldhuissen DJ, Waldenstrom A, Warren M, Westheim A, Zannad F, Fleming T (2004) Targeted anticytokine therapy in patients with chronic heart failure: Results of the randomized etanercept worldwide evaluation (RENEWAL). Circulation 109:r76-r84
8. Kwon HJ, Cote TR, Cuffe MS, Kramer JM, Braun MM (2003) Case reports of heart failure after therapy with a tumor necrosis factor antagonist. Ann Intern Med 138:807-811
9. de'Clari F, Salani I, Safwan E, Giannacco A (2002) Sudden death in a patient without heart failure after a single infusion of 200 mg infliximab: does TNF alpha have protective effects on the failing heart or does infliximab have direct harmful cardiovascular effects? Circulation 105:e183
10. Khan AH, Spodick DH (1972) Rheumatoid heart disease. Semin Arthritis Rheum 1:327-337
11. Wolfe F, Michaud K (2004) Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy. Am J Med 116:305-311
12. Hegewisch S, Weh HJ, Hossfeld DK (1990) TNF induced cardiomyopathy. Lancet 2:294-295
13. Mann DL, Young JB (1994) Basic mechanisms in congestive heart failure: recognizing the role of proinflammatory cytokines. Chest 105:897-904
14. Kelly RA, Smith TW (1997) Cytokines and cardiac contractile function. Circulation 95:778-781
15. Seta Y, Shan K, Bozkurt B, Oral H, Mann DL (1996) Basic mechanisms in heart failure: the cytokine hypothesis. Card Fail 2:243-249
16. Aikawa R, Nitta-Komatsubara Y, Kudoh S, Takano H, Nagai T, Yazaki Y, Nagai R, Komuro I (2002) Reactive oxygen species induce cardiomyocyte apoptosis partly through TNF alpha. Cytokine 18:179-183
17. Bradham WS, Bozkurt B, Gunasinghe H, Mann D, Spinale FG (2002) Tumor necrosis factor alpha and myocardial remodeling in progression of heart failure: a current perspective. Cardiovasc Res 53:822-830
18. Ferrari R, Bachetti T, Confortini R, Opasich C, Febo O, Corti A, Cassani G, Visioli O (1995) Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 92:1479-1486
19. Sack MN, Smith RM, Opie LH (2000) Tumor necrosis factor in myocardial hypertrophy and ischaemia: an anti-apoptotic perspective. Cardiovasc Res 45:68-695
20. Hofbauer KH, Schoof E, Kurtz A, Sander P (2002) Inflammatory cytokines stimulate adrenomedullin expression through nitric oxide dependent and independent pathways. Hypertension 39:161-167
21. Kurrelmeyer KM, Michael LH, Baumgarten G, Taffett GE, Peschon JJ, Sivasubramanian N, Entman ML, Mann DL (2000) Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. Proc Natl Acad Sci USA 97:5456-5461
22. Sugamori T, Ishibashi Y, Shimada T, Takahashi N, Sakane T, Ohata S, Kunizawa Y, Inoue S, Nakamura K, Ohta Y, Shimizu H, Katoh H, Oyake N, Murakami Y, Hashimoto M (2002) Increased nitric oxide in proportion to the severity of heart failure in patients with dilated cadiomyopathy: close correlation of tumor necrosis factor with systemic and local production of nitric oxide. Circ J 266:627-632
23. Aukrust P, Ueland T, Lien E, Bendtzen K, Muller F, Andreassen AK, Nordoy I, Aass H, Espevik T, Simonsen S, Froland SS, Gullestad L (1999) Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 83:376-382